Adelphi Values has an experienced global team of qualitative researchers, health economists, statisticians, creative scientists, clinicians and strategists with industry experience, who truly understand the need to develop evidence and communicate value throughout the product lifecycle.
Below is a selection of our projects, presented according to therapeutic or strategic/methodological area. It is not exhaustive, and we would be happy to provide further information on request.
Visual aid and flyer for a drug in pelvic organ prolapse
Value demonstration and communication of UK burden of nausea and vomiting during pregnancy
Report on the humanistic burden and psychometric validation of the breast pain and vaginal bleeding e-diaries, the breast sensations and vaginal bleeding impact questionnaires and the treatment satisfaction questionnaire
FDA meeting on a functioning claim for cyclical mastalgia
Psychometric analysis of quality of life questionnaires in women’s health
Data entry and analysis of SMILE data received from a clinical trial in women’s health
Generation of utility measures in women’s health and rescoring of the Women’s Health Questionnaire (WHQ)
Patient preference and utility study for an injectable hormone treatment
EVAPIL-R communications and strategic advice regarding the modification of existing PRO measures in women’s health
Development of a PRO best practices document – interactions with international regulatory and HTA agencies in women’s health
Market access tools implementation guide in ovarian cancer
Standalone budget impact models in ovarian cancer
Evaluation of patient perspectives on oral versus intravenously-administered treatments for ovarian cancer
Survey development for treatment preference in ovarian cancer
Provision of consulting services to support PRO labelling and publication strategy for a clinical development program in ovarian cancer
Cognitive debriefing interviews to assess usability of an ePRO device for use in forthcoming clinical trials in ovarian cancer
Literature and PRO review in ovarian cancer and pain consultancy
Literature review and consultancy on ovarian cancer
Strategic consultation on oncology endpoints and analysis in ovarian cancer
Psychometric evaluation and score interpretation of the national comprehensive cancer network-functional assessment of cancer therapy ovarian symptom Index-18 administered with patients who have advanced ovarian cancer
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.